Rebecca Robbins1, Renee Cole2, Chidera Ejikeme3, Stephanie L Orstad4, Sima Porten5, Carolyn A Salter6, Tatiana Sanchez Nolasco7, Dorice Vieira8, Stacy Loeb9. 1. Harvard Medical School, Boston, MA, USA; Brigham & Women's Hospital, Boston, MA, USA. Electronic address: RRobins4@bwh.harvard.edu. 2. Department of Urology, University of Michigan, Ann Arbor, MI, USA. 3. Harvard College, Cambridge, MA, USA. 4. Division of General Internal Medicine and Clinical Innovation, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA. 5. Department of Urology, University of California, San Francisco, USA. 6. Madigan Army Medical Center, USA. 7. Department of Urology and Population Health, NYU School of Medicine, New York, NY, USA. 8. NYU Grossman School of Medicine, New York, NY, USA; Department of Population Health, NYU School of Medicine, New York, NY, USA. 9. Departments of Urology and Population Health, NYU School of Medicine and Manhattan Veterans Affairs, New York, NY, USA.
Abstract
OBJECTIVE/ BACKGROUND: To examine the impact of prostate cancer (PCa) on sleep health for patients and caregivers. We hypothesized that sleep disturbances and poor sleep quality would be prevalent among patients with PCa and their caregivers. PATIENTS/ METHODS: A systematic literature search was conducted according to the Preferred Reporting Items for a Systematic Review and Meta-analysis guidelines. To be eligible for this systematic review, studies had to include: (1) patients diagnosed with PCa and/or their caregivers; and (2) objective or subjective data on sleep. 2431 articles were identified from the search. After duplicates were removed, 1577 abstracts were screened for eligibility, and 315 underwent full-text review. RESULTS AND CONCLUSIONS: Overall, 83 articles met inclusion criteria and were included in the qualitative synthesis. The majority of papers included patients with PCa (98%), who varied widely in their treatment stage. Only 3 studies reported on sleep among caregivers of patients with PCa. Most studies were designed to address a different issue and examined sleep as a secondary endpoint. Commonly used instruments included the Insomnia Severity Index and European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaires (EORTC-QLQ). Overall, patients with PCa reported a variety of sleep issues, including insomnia and general sleep difficulties. Both physical and psychological barriers to sleep are reported in this population. There was common use of hypnotic medications, yet few studies of behavioral interventions to improve sleep for patients with PCa or their caregivers. Many different sleep issues are reported by patients with PCa and caregivers with diverse sleep measurement methods and surveys. Future research may develop consensus on validated sleep assessment tools for use in PCa clinical care and research to promote facilitate comparison of sleep across PCa treatment stages. Also, future research is needed on behavioral interventions to improve sleep among this population.
OBJECTIVE/ BACKGROUND: To examine the impact of prostate cancer (PCa) on sleep health for patients and caregivers. We hypothesized that sleep disturbances and poor sleep quality would be prevalent among patients with PCa and their caregivers. PATIENTS/ METHODS: A systematic literature search was conducted according to the Preferred Reporting Items for a Systematic Review and Meta-analysis guidelines. To be eligible for this systematic review, studies had to include: (1) patients diagnosed with PCa and/or their caregivers; and (2) objective or subjective data on sleep. 2431 articles were identified from the search. After duplicates were removed, 1577 abstracts were screened for eligibility, and 315 underwent full-text review. RESULTS AND CONCLUSIONS: Overall, 83 articles met inclusion criteria and were included in the qualitative synthesis. The majority of papers included patients with PCa (98%), who varied widely in their treatment stage. Only 3 studies reported on sleep among caregivers of patients with PCa. Most studies were designed to address a different issue and examined sleep as a secondary endpoint. Commonly used instruments included the Insomnia Severity Index and European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaires (EORTC-QLQ). Overall, patients with PCa reported a variety of sleep issues, including insomnia and general sleep difficulties. Both physical and psychological barriers to sleep are reported in this population. There was common use of hypnotic medications, yet few studies of behavioral interventions to improve sleep for patients with PCa or their caregivers. Many different sleep issues are reported by patients with PCa and caregivers with diverse sleep measurement methods and surveys. Future research may develop consensus on validated sleep assessment tools for use in PCa clinical care and research to promote facilitate comparison of sleep across PCa treatment stages. Also, future research is needed on behavioral interventions to improve sleep among this population.
Authors: Adam V Benjafield; Najib T Ayas; Peter R Eastwood; Raphael Heinzer; Mary S M Ip; Mary J Morrell; Carlos M Nunez; Sanjay R Patel; Thomas Penzel; Jean-Louis Pépin; Paul E Peppard; Sanjeev Sinha; Sergio Tufik; Kate Valentine; Atul Malhotra Journal: Lancet Respir Med Date: 2019-07-09 Impact factor: 30.700
Authors: Michael Jefford; Andrew C Ward; Karolina Lisy; Karen Lacey; Jon D Emery; Adam W Glaser; Hannah Cross; Mei Krishnasamy; Sue-Anne McLachlan; Jim Bishop Journal: Support Care Cancer Date: 2017-04-22 Impact factor: 3.603
Authors: Kathryn E Flynn; Rebecca A Shelby; Sandra A Mitchell; Maria R Fawzy; N Chantelle Hardy; Aatif M Husain; Francis J Keefe; Andrew D Krystal; Laura S Porter; Bryce B Reeve; Kevin P Weinfurt Journal: Psychooncology Date: 2010-10 Impact factor: 3.894
Authors: R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton Journal: Eur J Cancer Date: 1994 Impact factor: 9.162
Authors: Jennifer L McQuade; Sarah Prinsloo; David Z Chang; Amy Spelman; Qi Wei; Karen Basen-Engquist; Carol Harrison; Zonghao Zhang; Debra Kuban; Andrew Lee; Lorenzo Cohen Journal: Psychooncology Date: 2016-09-20 Impact factor: 3.894